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Abstract
The NR4A nuclear receptor family member Nur77 (NR4A1) promotes thymocyte apoptosis during negative selection of
autoreactive thymocytes, but may also function in mature extrathymic T cells. We studied the effects of over-expression of
Nur77 on the apoptosis of murine peripheral T cells, including thymic-derived Foxp3+ regulatory (Treg) cells.
Overexpression of Nur77 in the T cell lineage decreased numbers of peripheral CD4 and CD8 T cells by ,80% compared
to wild-type (WT) mice. However, the proportions of Treg cells were markedly increased in the thymus (61% of CD4+Foxp3+
singly positive thymocytes vs. 8% in WT) and secondary lymphoid organs (40–50% of CD4+Foxp3+ T cells vs. 7–8% in WT) of
Nur77 transgenic (Nur77Tg) mice, and immunoprecipitation studies showed Nur77 was associated with a recently identified
HDAC7/Foxp3 transcriptional complex. Upon activation through the T cell receptor in vitro or in vivo, Nur77Tg T cells
showed only marginally decreased proliferation but significantly increased apoptosis. Fully allogeneic cardiac grafts
transplanted to Nur77Tg mice survived long-term with well-preserved structure, and recipient splenocytes showed
markedly enhanced apoptosis and greatly reduced anti-donor recall responses. Allografts in Nur77Tg recipients had
significantly increased expression of multiple Treg-associated genes, including Foxp3, Foxp1, Tip60 and HDAC9. Allograft
rejection was restored by CD25 monoclonal antibody therapy, indicating that allograft acceptance was dependent upon
Treg function in Nur77Tg recipients. These data show that compared to conventional CD4 and CD8 T cells, Foxp3+ Tregs are
relatively resistant to Nur77-mediated apoptosis, and that tipping the balance between the numbers of Tregs and
responder T cells in the early period post-transplantation can determine the fate of the allograft. Hence, induced expression
of Nur77 might be a novel means to achieve long-term allograft survival.
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Introduction
Nur77 (also known as NR4A1, TR3, NGFI-B or NAK1) is an
inducible orphan nuclear receptor comprised of an N-terminal
AF1 transactivation domain, a DNA binding domain containing
two zinc fingers, and a C-terminal ligand binding domain. Nur77
is necessary for induction of apoptosis in T-cell hybridomas [1,2]
and constitutive expression of Nur77 in thymocytes and various
cell lines leads to apoptosis [3,4]. In vivo, transgenic mice
expressing dominant-negative Nur77 are defective in the process
of negative selection whereas positive selection proceeds normally
[3,5]. However, Nur77-deficient mice are phenotypically normal,
suggesting functional redundancy between Nur77 and related
proteins [6].
Aspects of the mechanism by which Nur77 induces cell
apoptosis remain unclear. In resting thymocytes, Nur77 expression
is inhibited by the histone deacetylase, HDAC7 [7]. T cell receptor
(TCR) activation induces HDAC7 phosphorylation by the serine/
threonine kinase PKD1, and phosphorylated HDAC7 binds to 14-
3-3 protein and is exported from the nucleus, leading to depression
of Nur77 and other gene targets [7–10]. However, Nur77
downstream target genes responsible for regulating T cell
apoptosis remain to be identified. Although expression levels of
FasL and CD30 are elevated in Nur77 transgenic mice [4],
Nur77-mediated apoptosis is still intact in gld/gld (FasL mutant
mice) or CD302/2 mice, precluding FasL and CD30 as the
major downstream effectors of Nur77-related apoptosis in
thymocytes [11]. Moreover, negative selection of CD4+CD8+
doubly-positive thymocytes is intact in Fas- or CD30-deficient
mice, and constitutive expression of Nur77 in gld/gld mice rescues
the lymphoproliferative phenotype of the FasL mutant mice
[12,13]. In tumor cell lines, Nur77 initiates apoptosis by
translocating to the mitochondria, leading to release of cyto-
chrome c [14,15], activation of Apaf-1 and caspase-9, cleavage of
pro-caspase 3 and induction of apoptosis [16]. Over-expression of
Bcl-2 does not block Nur77-mediated apoptosis in T cells [11],
suggesting that either Nur77 transcription plays an especially
prominent role in initiating apoptosis in T cells or that Nur77
initiates a Bcl-2-independent mitochondrial apoptotic pathway.
Indeed, recent microarray studies showed Nur77 induces known
apoptotic genes such as FasL and TRAIL, but also novel genes
such as NDG1 and NDG2 that promote apoptosis in a Bcl-2-
independent manner [17].
In addition to promoting cell apoptosis through the mechanisms
outlined above, Nur77 can also function as an inhibitor of protein
kinase C (PKC) [18]. The C-terminal ligand-binding domain of
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rich loop of PKC-theta that is required for its catalytic activity,
preventing the phosphorylation of substrate by PKC-theta. Hence,
inhibition of catalytic activity by Nur77 can repress PKC-
mediated activation of AP-1 and NF-kB, with multiple down-
stream effects including preventing induction of anti-apoptotic
genes.
All these findings suggest an essential role of Nur77 in apoptotic
death accompanying negative selection in thymocyte develop-
ment. However, the role of Nur77 in induction of apoptosis in
mature T cells, and in the induction and/or maintenance of
peripheral tolerance is only poorly understood. Likewise, there are
no data as to the effects of Nur77 on the apoptosis of thymic-
derived Foxp3+ regulatory T (Treg) Treg vs. non-Treg cells. In the
current study, we evaluated the role of Nur77 on peripheral T cell
apoptosis by taking advantage of transgenic mice in which Nur77
was overexpressed in thymocytes and T cells using the Lck
promoter.
Results
Effect of Nur77 over-expression on peripheral T cell
populations
We found by quantitative real-time PCR (qPCR), that
expression of the inducible immediate early gene, Nur77, was
upregulated within 4 h of in vitro stimulation by PMA/ionomycin
(Figure 1a) or CD3 monoclonal antibody (mAb) (Figure 1b), and
returned to basal levels by 24 h in both non-Tregs and Tregs
(p.0.05). Using immunoprecipitation, we found that Nur77
formed a complex with HDAC7 and Foxp3 in resting Tregs
(Figure 1c), similarly to that of HDAC7 and Foxp3 [19], and
intranuclear staining for Nur77 protein showed that Nur77 was
expressed by a small population of naive CD4+ T cells, especially
CD4+ Foxp3+ T cells, but not by naive CD8+ T cells (Figure 1d).
After 24 h of in vitro stimulation, both CD4+ and CD8+ T cells
showed increased Nur77 protein expression, though levels of
expression were less than in CD4+ Foxp3+ T cells. Nur77 was not
expressed by CD19+ B cells, CD11b+ macrophages, CD11c+
dendritic cells or NK1.1+ natural killer cells, regardless of LPS
stimulation (Figure 1d).
In agreement with a previous analysis of these mice [3], we
found that thymocytes in Nur77Tg mice were markedly expanded
at the double-negative stage (DN, 59% vs. 5% in WT mice), with
little change in distribution of cells within DN1–DN4 (Figure 1e).
However, both CD4 and CD8 T cell populations in Nur77Tg
mice were significantly decreased in the spleen (5% CD4+ T cells
vs. 27% in WT mice, 1% CD8+ T cells vs. 13% in WT mice) and
lymph nodes (6% CD4+ T cells vs. 39% in WT mice; 2% CD8+ T
cells vs. 43% in WT mice) (Figure 1e). There was also a marked
expansion of the CD4+ Foxp3+ T cell population in Nur77Tg
mice compared to WT controls (Figure 1e), with increases in the
Foxp3+ to Foxp32 ratio of the spleen (1:2 vs. 1:15 in WT mice)
and lymph nodes (1:2 vs. 1:9 in WT mice). Thus, Nur77Tg mice
were not only lymphopenic but possessed an expanded population
of Tregs in their peripheral lymphoid organs.
Activation-induced apoptosis of Nur77Tg CD4 and CD8
but not Treg cells
Although Nur77 over-expression causes increased thymocyte
apoptosis during development, its effects on peripheral T cell
apoptosis after activation are unclear. Whole splenocytes from WT
or Nur77Tg mice were stimulated for 72 h with soluble CD3 mAb
(1 mg/ml) alone or CD3 plus CD28 mAbs (0.5 mg/ml). Far fewer
live Nur77Tg cells were recovered after in vitro stimulation as
compared to WT splenocytes (Figure 2a). Similar differences were
seen after stimulation for 72 h with PMA plus ionomycin; both
CD4+ and CD8+ T cells from Nur77Tg mice showed significantly
increased apoptosis after activation as compared to WT T cells
(Figure 2b). We used a parent-to-F1 adoptive transfer model to
assess the effects of Nur77 over-expression on T cell survival upon
allogeneic stimulation in vivo. Use of Nur77Tg mice as a source of
donor T cells led to a markedly reduced recovery of T cells after
72 h as compared to use of T cells from WT mice (Figure 2c),
suggesting markedly increased death of Nur77Tg T cells as a result
of alloantigen-induced T cell activation and proliferation in vivo.
To directly compare the impact of Nur77 over-expression on
susceptibility to apoptosis in non-Treg vs. Treg cells,
CD4+CD252 and CD4+CD25+ T cell populations were purified
by MACS separation and stimulated in vitro with PMA/
ionomycin and IL-2; T cell apoptosis was detected by Annexin
V staining. Nur77 overexpression led to increased apoptosis of
untreated non-Treg cells compared to WT cells, whereas Tregs
from both Nur77Tg and WT mice showed comparable low rates
of apoptosis at serial time points (Figure 3). Assessment of pro-
apoptotic and anti-apoptotic gene expression by resting and
activated cells showed comparable data for Nur77Tg Treg cells
and non-Treg cells except that Nur77Tg Tregs showed greater
upregulation of Bcl-2 (p,0.01) upon activation (Figure S1).
Collectively, these data indicate that Treg cells are markedly
more resistant to Nur77-induced apoptosis than non-Treg cells.
Impaired proliferation of Nur77Tg T cells after activation
To assess the effects of Nur77 on T cell activation and
proliferation, WT or Nur77Tg splenocytes were labeled with
CFSE and stimulated with soluble CD3 or CD3 plus CD28 mAbs
for 48 to 72 h. T cells from Nur77Tg mice showed much more
apoptosis than T cells from WT mice after in vitro activation, but
residual T cell proliferation was detected after 48 h (Figure 4a) or
72 h (Figure 4b) of TCR ligation with or without CD28
costimulation, albeit to a less extent than WT controls. Similar
results were seen in vivo, using a parent-to-F1 adoptive transfer
model in which only the transferred donor T cells proliferate.
Nur77Tg T cells were still capable of proliferation upon allo-
activation in vivo, but with decreased proliferation capacity
compared to WT, and with lesser T cell recovery (Figure 4c).
These results show that Nur77Tg T cells proliferate less than WT
T cells in vitro and in vivo, consistent with compromise of T cell
proliferative responses by Nur77-induced apoptosis of activated T
cells.
Long-term allograft acceptance in Nur77Tg recipients
We undertook cardiac allografting across a full major
histocompatibility complex (MHC) disparity to assess the practical
effects of Nur77 overexpression in a disease model. We found that
whereas WT C57BL/6 (B6) mice rejected BALB/c donor heart
with a mean survival time (MST) of 7.660.8 d (n=6), Nur77Tg
mice spontaneously accepted BALB/c cardiac grafts (MST
.100 d, n=6) (Figure 5a, p,0.001). Since Nur77Tg mice are
lymphocytopenic but also contain a large fraction of CD4+CD25+
or CD4+Foxp3+ Treg cells, long-term allograft survival might
reflect a lack of sufficient numbers of effector T cells to mount an
alloresponse, their death by activation-induced apoptosis, or
suppression of alloresponses by a disproportionately increased
number of Foxp3+ Treg cells. To test these hypotheses, we first
undertook thymectomy and treatment of Nur77Tg or WT mice
with a depleting CD25 mAb (PC61) 7 days before cardiac
transplantation; the efficacy of CD4+CD25+ T cell depletion was
monitored by flow cytometry, as described [20]. Treg depletion in
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PLoS ONE | www.plosone.org 2 May 2008 | Volume 3 | Issue 5 | e2321Figure 1. Nur77 expression by thymocytes and peripheral T cells in WT and Nur77Tg mice. (a) Nur77 mRNA expression after T cell
activation using PMA/ionomycin or (b) CD3 mAb as shown by qPCR analysis of CD4+CD252 and CD4+CD25+ T cells; data expressed as fold increases
(mean6SD) above control set as 1. Nur77 expression at 4 h was comparable (p.0.05) for Tregs and non-Tregs, but significantly increased compared
to levels either at rest or after 24 h of activation (*p,0.01). (c) Nur77 forms a complex with HDAC7 and Foxp3 as shown by immunoprecipitation of
HDAC7 from splenocytes, followed by SDS-PAGE and Western blotting with mAb to Foxp3 or Nur77. (d) Nur77 is mainly expressed by T cells upon
activation, especially by CD4+Foxp3+ Tregs, as shown by splenocytes stimulated with PMA/ionomycin or LPS for 24 h, followed by staining with cell
markers, and mAbs to Foxp3 and Nur77, or isotype controls (grey). Data are representative of 2 experiments with similar results. (e) Altered
thymocyte development, decreased peripheral T cell populations and expanded proportion of CD4+Foxp3+ fraction in Nur77Tg mice. Thymuses from
WT or Nurr77Tg mice were stained with CD4, CD8, CD25 and CD44 Abs; left upper panel showed the proportions of single positive (CD4+ or CD8+),
double positive and double negative cells, and left lower panel shows analysis of the double negative (DN) population 1–4 based on CD44 and CD25
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readily restored acute rejection of cardiac allografts in Nur77Tg
recipients (Figure 5a, p,0.001), indicating the residual small
populations of effector T cells in Nur77Tg mice could still mount
an effective alloresponse in the absence of Tregs.
We next considered whether Nur77-induced apoptosis played a
role in this transplant model. We evaluated secondary lymphoid
organs of Nur77Tg recipients at 7 and 21 d post-transplant.
Compared to WT recipients, there were markedly decreased CD4
and CD8 T cell populations in Nur77Tg recipients. Most of the
CD4+ and CD8+ T cells in the spleen (Figure S2a) and lymph
nodes (Figure S2b) of Nur77tg recipients were Annexin V-positive,
indicating significantly enhanced apoptosis of Nur77Tg effector T
cells upon allogeneic immune activation. By contrast, the
lymphoid tissues of Nur77Tg recipients contained about two-fold
more Foxp3+ Tregs as compared to the percentages of Tregs in
lymphoid tissues of WT recipients (Figure S2c).
We undertook adoptive transfer studies to further assess whether
Nur77-induced apoptosis was critical to permanent graft survival. As
few as 2610
6 purified WT T cells injected intravenously into
Nur77Tg recipients immediately after cardiac transplantation were
able to restore acute rejection (Figure 5b, p,0.001). To test whether
spontaneous allograft acceptance in Nur77Tg recipient was due to
the high Treg:Teff cell ratio compared to WT mice, we adoptively
Figure 2. Increased apoptosis of Nur77Tg T cells upon activation in vitro and in vivo. Splenocytes from WT or Nur77Tg mice were
stimulated with PMA/ionomycin for 72 h, followed by flow cytometry using T cell markers and Annexin-V and 7-AAD staining. (a) Live cells were
gated based on forward vs. side scatter, and (b) T cell apoptosis was based on Annexin-V and 7-AAD staining. (c) CFSE-labeled B6 or Nur77Tg spleen
and lymph node cells were adoptively transferred into B6/DBA F1 mice. After 72 h, donor-derived live CD4+ or CD8+ T cells were identified by gating
on H-2K
d (-) and H-2D
d (-) cells; figure in each square indicates percentage of the gated population. Data are representative of 3 experiments with
similar results.
doi:10.1371/journal.pone.0002321.g002
r
expression. Cells were also isolated from spleens and lymph nodes of WT or Nur77Tg mice and stained with CD4 and CD8 Abs, followed by
intranuclear staining for Foxp3. Figure in each square indicates the percentage of labeled cells, and data are representative of results from 8 mice per
group.
doi:10.1371/journal.pone.0002321.g001
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7 purified Nur77Tg CD4+CD252 T cells into
Nur77Tg recipients to increase the size of the non-Treg population
andrestorethenormalTreg:Teffratio.IncreasingthesizeoftheTeff
cell population in Nur77Tg recipients did not restore acute allograft
rejection and allografts were maintained long-term (n=4, p.0.05
compared to Nur77Tg recipients without adoptive transfer,
Figure 5c). These data indicate that the enhanced rate of
activation-induced apoptosis in Nur77Tg T cells renders them more
susceptible to control by Nur77-resistant Tregs.
We assessed recall responses of memory T cells in Nur77Tg mice
by ELISPOT assay. Since spleens of Nur77Tf mice were far less
cellular than those of WT mice, CD3+ T cells were purified from
WT and Nur77Tg recipient spleen 7 and 21 d post-transplant and
re-stimulated in vitro with donor-derived allogeneic antigen-
presenting cells (APC) or syngeneic controls (data not shown). In
comparison to WT, Nur77Tg recipients had a significantly reduced
donor specific responder frequency, as assessed by IFN-c spot-
forming cell numbers (Figure 5d). Collectively, these studies indicate
that spontaneous allograft acceptance in Nu77Tg recipients results
from both increased Treg cell numbers and increased activation-
induced apoptosis of T effector cells.
Intragraft gene expression
In contrast to cardiac allografts of WT mice harvested at day 7
post-transplant, histological examination showed only minor
mononuclear cell infiltration, well-preserved myocardium and
vasculature in allografts harvested from Nur77Tg recipients
(Figure 5e). The latter grafts also had negligible numbers of
TUNEL+ cells (data not shown), indicating that T cells underwent
activation-induced apoptosis in secondary lymphoid organs rather
than in the graft itself. We next undertook evaluation of intragraft
gene expression by qPCR, grafts harvested at 7 d post-transplant
from the two groups, as well as at 21 d post-transplant in the case
of Nur77Tg recipients. Comparison of intragraft events at 7 d
post-transplant showed that allografts from Nur77Tg had
decreased levels of CD3 but markedly increased levels of Nur77,
consistent with infiltration by small numbers of T cells that highly
expressed Nur77 when compared to WT recipients (Figure 6).
Nur77Tg allografts also contained increased levels of Treg-
associated genes such as Foxp3 and HDAC9 [21] but only low
levels of the cytokines IL-6, IFN-c and TNF-a, suggesting
significantly diminished inflammation and increased Treg recruit-
ment into the allograft.
Figure 3. Resistance of Treg cells to activation-induced apoptosis. CD4+CD252 and CD4+CD25+ were isolated by MACS separation and
stimulated in vitro with PMA/ionomycin plus IL-2 for 0, 24, 48 and 72 h (IL-2 alone as no stimulation control). T cell apoptosis at the indicated time
points was detected by Annexin V staining and flow cytometry analysis. Histogram data with the figure in each gated population indicating
percentage of Annexin V+ cells in the total (left panels) or live (right panels) cell populations. Data are representative of 3 experiments with similar
results.
doi:10.1371/journal.pone.0002321.g003
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PLoS ONE | www.plosone.org 5 May 2008 | Volume 3 | Issue 5 | e2321Figure 4. Impaired proliferation of Nur77Tg T cells. (a) Impaired T cell proliferation of CFSE-labeled Nur77Tg mice after 48 h of in vitro
activation with soluble CD3 mAb alone or plus CD28 mAb; figure in each square indicates percentage of the gated population. (b) Assessment of T
cell proliferation after 72 h; experimental details as for previous panel. (c) Impaired proliferation of Nur77Tg T cells after allo-stimulation in vivo.
Allogeneic T cell responses were generated by i.v. injection of CFSE-labeled B6 or Nur77Tg spleen and lymph node cells into B6/DBA F1 recipients.
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apoptosis in T cells
Nur77 was identified by DNA microarray as an immediate
early gene induced by a thymotoxic organotin compound, di-n-
butylin dichloride (DBTC) [22]. While DBTC treatment in vitro
and in vivo was shown to induce thymocyte apoptosis, we
investigated whether DBTC had the same effect on peripheral T
cells. Accordingly, WT CD4+CD252 and CD4+CD25+ T cell
populations were fractionated using magnetic beads to .90%
purity, and 1610
6 cells of each fraction were cultured in the
presence of DBTC (3 mM, dissolved in ethanol) or ethanol
carrier alone (the final concentration of ethanol in the culture
medium was 0.1%). Cells were harvested after 4 h and Nur77
mRNA expression detected by qPCR. We found that DBTC
treatment induced Nur77 expression equally in both
CD4+CD252 and CD4+CD25+ Tc e l lp o p u l a t i o n s( p ,0.05
compared to ethanol alone, Figure 7a). We also studied the effect
of inducing T cell apoptosis in vivo with DBTC treatment. Mice
were fed DBTC and apoptosis of non-Treg and Treg cells in vivo
assayed by Annexin V staining after 72 h. DBTC treatment in
vivo caused a markedly increase in the Treg vs. Teff ratio
(Figure 7b), consistent with the differential effects of Nur77
transgene expression on CD4+CD252 Tc e l l sv e r s u sC D 4 +
CD25+ Treg cells.
Discussion
This study showed remarkable effects on the immune system
caused by the over-expression of Nur77 in T cells. In the only
previous study of these mice in a disease model, the incidence
and severity of collagen-induced arthritis was significantly
decreased in Nur77-transgenic mice versus WT controls [23].
Attenuation of the disease was associated with apoptosis of
transgenic T cells and decreased production of collagen type II-
specific IgG2a antibodies, consistent with impaired capacity for
normal T cell proliferation and provision of help for T cell-
dependent B cell functions. In contrast, we now show significant
therapeutic consequences of the differential susceptibility of
Treg versus non-Treg cells to undergo Nur77-induced apopto-
sis.
As expected, given its pro-apoptotic role during thymocyte
development, Nur77 over-expression led to a marked reduction in
the numbers of mature T cells in the periphery. However, the
residual peripheral T cells themselves showed markedly increased
rates of apoptosis upon activation in vitro or in vivo, indicating that
Nur77 is an important regulator of mature T cell apoptosis. Despite
their decreased numbers and increased rates of apoptosis following
cellactivation,intheabsenceofTregs,TcellsofNur77Tgmicewere
able to promote rejection of allografts at a similar pace to that
exerted by WT T cells. By contrast, CD4+CD25+ naturally
occurring Tregs were more resistant to apoptosis induced by
Nur77 over-expression, such that secondary lymphoid tissues of
Nur77Tg mice had a markedly expanded population of Foxp3+
Tregs. The spontaneous long-term acceptance of fully MHC-
mismatched cardiac allografts in this strong-responder strain
combination highlights the extent to which the Treg to T effector
cell ratio can dampen host immune responses.
Allografts in Nur77Tg recipients at both peri-transplant and
later periods were infiltrated by Foxp3+ Tregs, and had increased
expression of several genes recently implicated in Treg biology,
including HDAC9, TIP60 and Foxp1 [19,21]. They also showed
decreased levels, compared to allografts in WT recipients, of pro-
inflammatory cytokines and chemokine receptors important to
allograft rejection in this model [24]. The finding that Nur77
could be co-immunoprecipitated with HDAC7, extends to Foxp3+
Tregs the known relationship of these two molecules in T cell
development, especially within the thymus [3,7]. Further charac-
terization of the roles of HDAC7, HDAC9 and related proteins in
Tregs is underway in our laboratory [19,21].
Despite the presence of relatively large numbers of Tregs in
Nur77Tg mice, adoptive transfer of small numbers of WT T
effector cells led to prompt rejection of cardiac allografts, while
transferring even large numbers of Nur77Tg T effector cells, so as
to increase the T effector to Treg cell ratio, did not abrogate
spontaneous allograft acceptance, pointing to the important role of
T effector cell apoptosis in achieving transplant tolerance. Hence,
efforts to induce allograft acceptance as a result of Nur77 over-
expression will likely require enhanced expression in both CD4
and CD8 T cells whereas, at the least, associated enhancement of
Nur77 expression in Treg cells does not appear to have negative
consequences.
Previous studies showed using Foxp3 transgenic mice that
increased expression of Foxp3 led to increased apoptosis of
CD4+CD252 T cells following TCR activation, along with
upregulation of pro-apoptotic genes such as FasL, TRAIL. TNF-a
and Bad [25]. The Fas-FasL pathway was also implicated in the
control of Treg apoptosis in studies of FasL mutant (gld) mice;
these contain markedly increased numbers of CD4+CD25+ Tregs
within the CD4 population [26]. Recent data suggest that adult
human Foxp3+ Tregs are comprised of a naive (CD4+CD25+
CD45RA
hi) CD952 subset, as well as a more frequent memory
(CD4+CD25+CD45RO) CD95+ subset, and that these two
subsets differ in their susceptibility to CD95L-induced apoptosis
[27]. Thus, while the memory subset is prone to CD95L-mediated
death, naive Tregs are resistant. Tregs are known to be more
resistant than conventional T cells to activation-induced cell death
[28], and the current data indicate that Tregs are also more
resistant than conventional Tregs to Nur77-induced cell death.
In addition to transgenic approaches, Nur77 expression can be
modulated by physiologic and chemical agents. Nur77 was first
identified as an immediate-early gene induced by serum (9) or
TCR signaling in T cell hybridomas and thymocytes [1,2].
Natural and synthetic retinoic acids affect Nur77 activity through
its interaction with RAR and RXR; all-trans or 9-cis-retinoic
acids, which block activation-induced cell death, inhibit the
transcriptional activity of Nur77 (and expression of FasL) in T
cells [29,30]. By contrast, CD437, a RARc-specific agonist,
induces Nur77 expression through an unknown mechanism and
enhances Nur77-mediated activity through a Nur77-binding
response element [30,31].
With regard to effects of pharmacologic agents on Nur77
expression and function, thapsigargin inhibits endoplasmic
reticulum-dependent Ca
2+-ATPase, increases cytosolic Ca
2+ levels,
and induces Nur77 expression and causes apoptosis in T cells [32].
!After 72 h, donor derived allo-reactive T cells were identified by gating on H-2K
d (-) and H-2D
d (-) cells and T cell proliferation assessed by CFSE division
profiles; note different y-axis for WT vs. Nur77Tg T cells. Figure in each square indicates percentage of the gated population; data representative of3
experiments with similar results.
doi:10.1371/journal.pone.0002321.g004
r
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PLoS ONE | www.plosone.org 7 May 2008 | Volume 3 | Issue 5 | e2321Figure 5. Long-term acceptance of MHC mismatched cardiac allograft in Nur77Tg recipients. (a) BALB/c cardiac allografts were accepted
long-term by Nur77Tg recipients, in contrast to acute rejection in WT C57BL/6 recipients (p,0.001). Long-term survival was dependent upon Treg cell
function since Treg cell depletion by thymectomy and CD25 mAb therapy pre-transplant restored acute rejection in Nur77Tg recipients (p,0.001 vs.
control Nur77Tg mice). (b) Adoptive transfer of WT T cells restored acute allograft rejection in Nur77Tg mice (p,0.01); 2610
6 CD4+CD252 W TTc e l l s
purified using magnetic beads were injected i.v. injected into Nur77Tg recipients (n=4) immediately post-transplant. (c) Adoptive transfer of additional
Nur77Tg T cells did not restore allograft rejection in Nur77Tg recipients; 1610
7 CD4+CD252 WT T cells purified using magnetic beads were injected i.v.
intoNur77Tgrecipients(n=4)immediatelypost-transplant.(d)Significantlydecreaseddonor-specific responderfrequency inNur77TgrecipientsofBALB/
c cardiac allografts. Recipient spleens (n=3/group) were harvested at 7 or 21 d post-transplant and CD3+ T cells were isolated by MACS separation;
purified recipient T cells were re-stimulated in 96-well ELISPOT plates using irradiated donor splenocytes (donor-specific antigen) or recipient splenocytes
(syngeneic controls) at different stimulator to responder ratios. Recipient anti-donor responder frequencies were determined by IFN-c spot-forming cells
(SFC)/2610
5 recipient T cells (mean6SD); *p,0.01 and ** p,0.005 for WT vs. Nur77Tg data at corresponding time post-transplant. (e) Acute rejection of
BALB/callografts in WTrecipients(left) versus minimalleukocyte infiltrationandmyocardialorvascularinjuryinallografts harvestedat7 dpost-transplant
from Nur77Tg recipients (H&E-stained paraffin sections, original magnifications 6250).
doi:10.1371/journal.pone.0002321.g005
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inhibited by cyclosporin A, suggesting that calcineurin plays an
important role in its regulation. Cyclosporin A blocks apoptosis by
inhibiting the DNA binding activity of the transcription factor
Nur77 through the N-terminal region of the protein [33]. Lastly,
Nur77 was shown to be rapidly induced in vitro and in vivo in
thymocytes exposed to DBTC, and antisense oligonucleotide
inhibition of Nur77 expression prevented apoptosis induced by
DBTC, suggesting that DBTC caused thymocyte apoptosis by
inducing Nur77 expression [22].
Given our initial data, DBTC may be a suitable agent to test the
effects of pharmacologic induction of Nur77 in T cells, including
in experimental allograft models. Future studies from our group
will involve testing of this compound in allograft models, as well as
assessment of the effects of engineering of a dominant-negative
form of Nur77 on T cell and Treg function. Collectively, the
current data, along with the proposed studies, should provide a
basis for assessing whether manipulation of Nur77 levels by
pharmacologic or genetic means warrants further development
and testing in pre-clinical disease models.
Materials and Methods
Mice
Mice transgenic for Nur77, under control of the T cell–specific
lck proximal promoter as described [3], were backcrossed to the
C57BL/6 strain and maintained in our animal facility. WT
C57BL/6 (H-2
b), BALB/c (H-2
d), B6D2F1 and congenic Thy1.1
mice were purchased from The Jackson Laboratory (Bar Harbor,
ME). All studies were performed with a protocol approved by the
institutional animal care and use committee of The Children’s
Hospital of Philadelphia.
Reagents
We purchased CFSE (Molecular Probes), DBTC (Sigma),
antibodies against CD25 (PC-61, eBioscience), Foxp3 (Alexis),
HSC70 (Santa-Cruz), HDAC7 (Sigma), HDAC9 (BioVision),
Nur77 (IMG-528, IMGENEX), mAbs to cell lineage markers
(BD-PharMingen), and HRP-conjugated anti-rabbit, rat or goat
IgG antibodies (Santa-Cruz) for immunoprecipitation, Western
blotting and intranuclear staining.
Figure 6. Intragraft gene expression in Nur77Tg versus WT recipients. (a) Total RNA was extracted from 7 d cardiac allografts of WT
recipient, and 7 d and 21 d allografts of Nur77Tg recipients, and intragraft gene expression of Nur77, CD3, CD45, IL-6, TNF-a, Foxp1, Foxp3, GITR,
CTLA4 and HDAC9 was assessed by q PCR. Data were expressed as fold increases (mean6SD) above the normal BALB/c heart; *p,0.05 and **p,0.01
versus corresponding WT allograft data. Data are representative of 3 experiments with similar results.
doi:10.1371/journal.pone.0002321.g006
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Allogeneic T cell responses were generated by i.v. injection of
30610
6CFSE-labeledB6spleenandlymphnodecellsintoB6/DBA
F1 recipients, a parentRF1 MHC mismatch in which only donor
cells respond [34]. Splenocytes were harvested after 3 d and
incubated with CD4-PE, CD8-PE, CD25-PE, CD69-PE and
biotin-conjugated anti-H2K
d and anti-H2D
d mAbs. Donor-specific
alloreactive T cells were identified by gating on H-2K
d-a n dH - 2 D
d-
cells (FACSCalibur; BD Biosciences), and T cell proliferation was
assessed by CFSE division profiles [35].
For intracellular cytokine staining, splenocytes (3610
6/ml) were
stimulated for 4 h with PMA (3 ng/ml) /ionomycin (1 mM) in 24-
well plates in complete medium (RPMI 1640, 10% FCS, 2-ME,
penicillin /streptomycin) in the presence of Golgi-Stop
(BD-PharMingen). Cells were stained with cell surface markers
(CD4-PE or CD8-PE, biotin-conjugated H-2K
d or H-2D
d mAbs
followed by SA-Percp), fixed, permeabilized and with anti-IFN-c-
APC or anti-IL-2-APC mAb. Foxp3 expression was detected
according to the manufacturer’s instructions (eBioscience). Briefly,
cells were labeled with surface markers and fixed overnight,
permeabilized and stained with rat anti-Foxp3-PE mAb (rat IgG2a
isotype control) and rabbit-anti-mouse Nurr77 (rabbit IgG isotype
control), followed by FITC-conjugated anti-rabbit IgG, and analysis
(FACSCalibur).
T cell purification and stimulation
CD4+ T cellwerenegatively selected (.90%) with magnetic beads
(Miltenyi) and separated into CD25+ and CD252 populations;
Figure 7. DBTC induces Nur77 and differentially promotes non-Treg vs. Treg cell apoptosis. (a) WT CD4+CD252 and CD4+CD25+ T cell
populations were fractionated using magnetic beads (.90% purity) and cultured for 4 h in RPMI medium plus 3 mM DBTC or ethanol alone (final
concentration of 0.1% ethanol). Nur77 mRNA expression was detected by qPCR; data are expressed as fold increase (mean6SD) above control set as
1. DBTC treatment increased Nur77 mRNA in both cell populations (p,0.05 for CD4+CD252 vs. control, p,0.01 for CD4+CD25 vs. control), but levels
of induction at 4 h were not significantly different (p.0.05) for the groups treated with DBTC. (b) C57BL/6 mice were fed DBTC (60 mg/kg/day) for
3 d, sacrificed and single cell suspensions from spleens and lymph nodes were stained with T cell markers and Foxp3 mAb. Flow cytometric analysis
of Foxp3 expression in the CD4+ T cell population is representative of 4 mice/group, and the percentage of the gated population is indicated.
doi:10.1371/journal.pone.0002321.g007
Nur77 and Allograft Acceptance
PLoS ONE | www.plosone.org 10 May 2008 | Volume 3 | Issue 5 | e2321purity was .90% as assessed by flow cytometry. T cells were
stimulated in vitro with soluble or plate-bound CD3 mAb, CD3 plus
CD28 mAbs (BD Pharmingen) or PMA (3 ng/ml)/ionomycin
(1 mM) plus IL-2.
qPCR
RNA was extracted using RneasyH Mini Kit (QIAGEN) and
reverse transcription of RNA samples (2 mg) performed with
random hexamers (ABI PRISM 5700, Applied Biosystems).
Specific primer and probe sequences for target genes (TaqMan
PDAR, Applied Biosystems) were used for qPCR amplification of
total cDNA (50 ng). Relative quantitation of target cDNA was
determined by setting the control value to 1; changes in cDNA
content were expressed as fold increases above the set control
value. Differences in cDNA input were corrected by normalizing
signals obtained with specific primers to ribosomal RNA.
Nonspecific amplification was excluded by performing RT-PCR
reactions without target cDNA.
DBTC treatment in vitro and in vivo
DBTC was dissolved in ethanol absolute to make a stock
solution. For in vitro experiments, cells were incubated with 3 mM
DBTC dissolved in 0.1% ethanol (final concentrations). For in vivo
treatment, DBTC stock solution was diluted in corn oil and given
by gavage at a dose of 60 mg/kg; control animals received the
same volume of corn oil and 5% ethanol.
Annexin V staining
We performed qualitative cell apoptosis assay using the Annexin
V-PE apoptosis detection kit (BD-Pharmingen) according to the
manufacturer’s instructions. Briefly, cells were washed twice with
cold PBS, resuspended in binding buffer (1610
6 cells/ml), 100 ml
of solution was incubated with 5 ml of Annexin V-PE and 5 mlo f
7-AAD for 15 min at RT in the dark, and 400 ml of binding buffer
was added and cells analyzed by flow cytometry.
In vitro suppression assay
Assays of Treg function in vitro were performed using MACS-
purified CD4+CD252 T cells as effector cells and CD4+CD25+
cells or retroviral transfected Foxp3 expressing CD4+ T cells as
regulatory cells. The proliferation of CFSE-labeled CD4+CD252
cell, driven by CD3 mAb (0.5 mg/ml) plus c-irradiated syngeneic
APC, was assessed by flow cytometric analysis of CFSE dilution
after 72 h [21].
ELISPOT assay
Immunospot assays for IFN-c were performed by coating
ELISPOT plates (BD Pharmingen) with anti-IFN-c mAb, followed
by blocking, addition of MACS-purified CD3+ T cells isolated
from cardiac transplant recipient spleens, and use of plus
irradiated (2000 Rad) donor splenocytes as stimulators; recipient
splenocytes served as syngeneic controls [21]. After 24 h, cells
were discarded and wells washed, followed by use of biotinylated
anti-IFN-c mAb, streptavidin-HRP and substrate reaction. Spots
were counted automatically using ImmunoSpot Analyzer (Cellular
Technology). Recipient anti-donor responder frequency was
determined by IFN-c spot-forming cells (SFC)/2610
5 recipient
splenocytes.
Western blots
Grafts were sonicated in lysis buffer containing Triton X-100
and protease inhibitors, followed by centrifugation and quantifi-
cation of supernatant protein content. Proteins were reduced,
resolved by SDS-PAGE and transferred to nitrocellulose mem-
branes. Membranes were blocked, incubated with primary and
HRP-linked secondary antibodies, followed by substrate reaction
and film development [21].
Immunoprecipitation
Immunoprecipitation was performed using the Seize
H X
Mammalian Immunoprecipitation Kit (PIERCE) according to
the manufacturer’s instructions. Briefly, antibodies were bound
and cross-linked to immobilized protein G for 2 h in room
temperature, 5610
6 cells were lysed using the M-PERH reagent,
and extracted cell samples were mixed 1:1 with Bind/Washing
Buffer and added to the antibody-coupled gel in the spin cup
column. Samples were incubated overnight at 4uC with end-over-
end mixing, eluted with ImmunoPure
H elution buffer and
prepared for SDS-PAGE [21].
In vivo depletion of Treg and adoptive transfer
Tregs were depleted by undertaking thymectomy under
tracheal intubation 7 d pre-transplant and daily injection of the
depleting CD25 mAb, PC61 mAb (250 mg, i.p.), for 3 consecutive
days post-thymectomy; the efficacy of depletion was monitored by
flow cytometry [20]. For adoptive transfer, 2610
6 MACS-purified
CD4+CD252 T cells from naive mice were injected i.v. into
recipient mice immediately post-transplantation.
Cardiac transplants
Intra-abdominal vascularized murine heart transplantation
(BALB/c to C57BL/6) was performed by standard methods
[36]. Briefly, donor ascending aorta and pulmonary artery were
anastomosed end-to-side to recipient infrarenal aorta and inferior
vena cava, respectively. Graft survival was assessed daily by
abdominal palpation; rejection was defined as total cessation of
cardiac contraction and was confirmed by histology. Portions of
harvested allografts were fixed in formalin and paraffin embedded,
or snap-frozen and analyzed by immunoperoxidase staining with a
panel of mAbs.
Statistics
Allograft survival was used to generate Kaplan-Meier survival
curves, and comparison between groups was performed by log-
rank analysis.
Supporting Information
Figure S1 Pro- and anti-apoptotic gene expression by WT and
Nur77Tg Tregs. CD4+CD252 and CD4+CD25+ cell population
were isolated from WT and Nur77Tg mice using magnetic beads,
followed by qPCR analysis (mean6SD) of gene expression in
resting cells (black) or after 24 h of PMA/ionomycin stimulation
(blue).
Found at: doi:10.1371/journal.pone.0002321.s001 (0.80 MB TIF)
Figure S2 T cell apoptosis post cardiac allografting. Cardiac
transplantation was performed from BALB/c donor to C57BL/6
or Nur77Tg recipients. Recipient (a) spleen and (b) lymph node
cells were prepared 7 or 21 d later and stained with CD4, CD8
and Annexin V, followed by flow cytometry analysis. Data are
expressed as dot plots, with the figure in each square indicating
the percentage of Annexin V+ cells within the gated population.
(c) Spleens and lymph nodes were harvested from WT or
Nur77Tg recipients at 7 or 21 d after cardiac transplantation.
Single cell suspension was prepared and stained with T cell
markers and Foxp3. CD4+Foxp3+ T cell populations in the
Nur77 and Allograft Acceptance
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cytometry. Data are expressed as dot plots, with the figure in
each square indicating the percentage of positive cells within the
gated population.
Found at: doi:10.1371/journal.pone.0002321.s002 (4.85 MB TIF)
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